Rising Prevalence Of Meningitis To Boost The Growth Of Global Meningitis Treatment Market

Meningitis Treatment Market
Meningitis Treatment Market

Meningitis Treatment Market, By Type (Bacterial, Viral, Fungal, Parasitic), Drug Type (Antibiotics Agents, Antiviral Agents, Corticosteroids, Others), Vaccine Type (Meningococcal Conjugate Vaccine, Meningococcal Polysaccharide Vaccine, Combination Vaccine, Others), Diagnostic Test (Lateral Flow Assay, PCR Assay, Latex Agglutination Tests, Elisa Tests and Culture Tests), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) – by Region (Europe, North America, Asia Pacific, Africa, Latin America and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

The global Meningitis Treatment Market is estimated to be valued at US$ 185 million by 2030 and is expected to exhibit a CAGR of 4.1 % over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Meningitis is a contagion and infection of the liquid and membranes near the brain and spinal cord. These sheaths are known as meninges. The infection from meningitis usually causes prodromes such as migraine, fever and a firm neck. Many meningitis incidence in the United States are occurred due to a viral infection. However meningitis can also be occurred by bacteria, microbes and fungus.

In some incidences meningitis decreases without any treatment. Others can lead to fatality and need urgent antibiotic therapeutics. The treatment is based on the kind of meningitis one is suffering from. Acute bacterial meningitis is cured with IV antibiotics and often corticosteroids. This aids to guarantee quick healing and decreases the threat of side effects, such as intellect bulging and attacks.

Competitive Landscape:

Key players involved in the growth of global Meningitis Treatment Market are MATINAS BIOPHARMA HOLDINGS, INC., Hikma Pharmaceuticals PLC, Zydus Cadila, Bausch Health Companies Inc., Mylan N.V., Lupin, Novartis AG, Beximco Pharmaceuticals Ltd, Astral SteriTech Pvt. Ltd, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd, Aurobindo Pharma, and Pfizer Inc.

Market Key Drivers:

Rising prevalence of meningitis is expected to augment the growth of global meningitis treatment for market. For instance, as per CDC, around 2.5 million people suffer from meningitis annually across the globe.

The rise in pathogenic infections is projected to propel the growth of global Meningitis Treatment Market. For instance, as per WHO, infectious diseases leads to mortality of around 17 million people annually worldwide.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global meningitis treatment for market. COVID-19 has created an extreme global public health crisis that has affected almost every sector. The rise in pandemic has led to the delay in other surgeries and led to less hospital visits. These all factors led to the downfall of the market growth.

Key Takeaways:

The global Meningitis Treatment Market is anticipated to exhibit a CAGR of 4.1% during the forecast period due to the rising R&D for the expansion of the product. For instance, industries in the clinical device sector invested around 8% of their total revenue on R&D projects, replicating the competitive nature of this sector.

Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the global meningitis treatment for market due to rising prevalence of meningitis, increasing product development, rising healthcare expenditure. For instance, as per CDC, around 375 total cases of meningococcal disease were diagnosed in U.S in 2019.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more